FDA Issues Caution on Unapproved Blood Sugar Monitoring Wearables: Navigating the Risks of Noninvasive Glucose Tracking
FDA Issues Caution on Unapproved Blood Sugar Monitoring Wearables: Navigating the Risks of Noninvasive Glucose Tracking. The U.S. Food and Drug Administration (FDA) has recently issued a warning regarding the use of smartwatches and rings that advertise the ability to measure blood glucose levels without the need for needle pricks. This advisory encompasses devices[ ► ]
